Elpiscience Biopharmaceuticals

About:

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies

Website: http://www.elpiscience.com/

Twitter/X: elpiscience

Top Investors: Cormorant Asset Management, Tencent, Hillhouse Investment, Lilly Asia Ventures, CDH Investments

Description:

Elpiscience is a clinical-stage biopharmaceutical company focused on developing next-generation cancer immunotherapies. The company has a robust pipeline of globally innovative molecules, covering wide range of targets in immuno-oncology. Founded and managed by a team of biopharma industry leaders and scientists, Elpiscience endeavors to advance at least one innovative molecule into the clinic each year to benefit cancer patients worldwide.

Total Funding Amount:

$260M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2017-01-01

Contact Email:

info(AT)elpiscience.com

Founders:

Darren Ji, Hongtao Lu

Number of Employees:

51-100

Last Funding Date:

2021-05-13

IPO Status:

Private

Industries:

© 2025 bioDAO.ai